ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

AZN Astrazeneca Plc

11,988.00
-38.00 (-0.32%)
26 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Astrazeneca Plc LSE:AZN London Ordinary Share GB0009895292 ORD SHS $0.25
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -38.00 -0.32% 11,988.00 12,014.00 12,018.00 12,144.00 11,882.00 12,070.00 2,340,814 16:35:09
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 45.81B 5.96B 3.8415 31.28 186.27B

AstraZeneca PLC Total Voting Rights - Replacement (9809A)

01/10/2015 4:15pm

UK Regulatory


Astrazeneca (LSE:AZN)
Historical Stock Chart


From Apr 2019 to Apr 2024

Click Here for more Astrazeneca Charts.

TIDMAZN

RNS Number : 9809A

AstraZeneca PLC

01 October 2015

HEADLINE ALTERATION

The headline for the (Company) announcement released on 1 October 2015 at 1430 hours (BST) under RNS No 9178A should read Total Voting Rights.

The announcement text is unchanged and is reproduced in full below.

Transparency Directive

Voting Rights and Capital

The following notification is made in accordance with the UK Financial Conduct Authority's Disclosure and Transparency Rule 5.6.1. On 30 September 2015 the issued share capital of AstraZeneca PLC with voting rights is 1,263,816,016 ordinary shares of US$0.25. No shares are held in Treasury. Therefore, the total number of voting rights in AstraZeneca PLC is 1,263,816,016.

The above figure for the total number of voting rights may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, AstraZeneca PLC under the UK Financial Conduct Authority's Disclosure and Transparency Rules.

A C N Kemp

Company Secretary

1 October 2015

This information is provided by RNS

The company news service from the London Stock Exchange

END

TVRUGGRCUUPAGCG

(END) Dow Jones Newswires

October 01, 2015 11:15 ET (15:15 GMT)

1 Year Astrazeneca Chart

1 Year Astrazeneca Chart

1 Month Astrazeneca Chart

1 Month Astrazeneca Chart

Your Recent History

Delayed Upgrade Clock